|
Post by peppy on Feb 14, 2018 16:20:17 GMT -5
So all this time Deerfield has been taking shares for debt and now they own Zero. Why? Quite frankly, I haven't been able to explain most things that happen with MNKD but I ll take a another stab. Conventional wisdom prior to this filing was that Deerfield was taking shares because they were in the know and expected share price increase would offset any gains expected by debt repayment. This is obviously false reasoning now. Is it possible that Deerfield had a very large short position and not enough available shares to close it out? So in actuality they needed those shares to close their short position. Make any sense? For the detectives on the board does their sale date jive with the purchase by Kresa? Does their filing date coincide with changes in short sale stats for that period? The only thing I dont like is they hold no shares at all. Deerfield has bought shares/for debt three times at three different prices since 2017. 10 million shares at $1.39 was memorable as price went down to .66 after. That buy was suspected as being to close a short position. Deerfield shorted MNKD all the way down, there is a newspaper article about deerfield using insurance information with newly approved medications. It seems that new medications that are put out by small makers, do not have the cash for all the studies, big Pharma destroys them, or buys them. also a deerfield stock for debt buy at 2.39, was that 5 million shares? there was another one also.... wasn't there? ?
|
|
|
Post by mytakeonit on Feb 14, 2018 16:35:27 GMT -5
I remember that well peppy. That's when I was able to buy a ton of cheap shares !!! YaHooooo !!!
|
|
|
Post by traderdennis on Feb 14, 2018 17:15:17 GMT -5
I find it concerning since Deerfield would have a better understanding of the company's potential than most and chose to sell. I would take this as a poor vote of confidence. I know others will say this is their business model but still. It is doubtful Deerfield held for any length of time at all
|
|
|
Post by #NoMoreNeedles on Feb 15, 2018 4:31:13 GMT -5
|
|
|
Post by akemp3000 on Feb 15, 2018 5:28:32 GMT -5
I find it concerning since Deerfield would have a better understanding of the company's potential than most and chose to sell. I would take this as a poor vote of confidence. I know others will say this is their business model but still. Dr. David Kendall, who is one of if not possibly the world's leader in the global diabetes business, has a far better understanding of the company's potential and yes, it's not Deerfield's business model to buy and hold shares.
|
|
|
Post by brotherm1 on Feb 15, 2018 5:38:28 GMT -5
“Focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. The company has commenced Phase 3 clinical trials in Europe of its lead product, the Technosphere Insulin System, to study its potential for the treatment of diabetes.” This is whale wisdom, or perhaps guppy wisdom?
|
|
|
Post by mnholdem on Feb 15, 2018 7:51:21 GMT -5
I find it concerning since Deerfield would have a better understanding of the company's potential than most and chose to sell. I would take this as a poor vote of confidence. I know others will say this is their business model but still. Dr. David Kendall, who is one of if not possibly the world's leader in the global diabetes business, has a far better understanding of the company's potential and yes, it's not Deerfield's business model to buy and hold shares. That is correct. Deerfield simply agreed to let MannKind pay its debt payments in the form of shares. Deerfield immediately converted them to cash by selling. The transaction has no bearing on Deerfield's confidence in MannKind or lack thereof. If Deerfield wanted to INVEST in MNKD stock, they would simply purchase shares or options on the market.
|
|
|
Post by mnkdfann on Feb 15, 2018 11:09:54 GMT -5
That is correct. Deerfield simply agreed to let MannKind pay its debt payments in the form of shares. Deerfield immediately converted them to cash by selling. The transaction has no bearing on Deerfield's confidence in MannKind or lack thereof. If Deerfield wanted to INVEST in MNKD stock, they would simply purchase shares or options on the market.
But the one does not preclude the other, does it? If Deerfield was interested in maintaining an investment in MNKD it certainly could keep / hold some of the shares MNKD paid them instead of converting them all. Unless it already had a sizable full position, perhaps.
|
|